BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16157917)

  • 1. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies.
    Crespel A; Genton P; Berramdane M; Coubes P; Monicard C; Baldy-Moulinier M; Gelisse P
    Neurology; 2005 Sep; 65(5):762-4. PubMed ID: 16157917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening of negative myoclonus by lamotrigine in a case of idiopathic focal epilepsy of children with long-term follow-up.
    Gélisse P; Genton P; Velizarova R; Serafini A; Crespel A
    Brain Dev; 2012 Mar; 34(3):248-50. PubMed ID: 21621357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of lamotrigine in juvenile myoclonic epilepsy.
    Buchanan N
    Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
    Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
    Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabling erratic myoclonus during lamotrigine therapy with high serum level--report of two cases.
    Janszky J; Rásonyi G; Halász P; Olajos S; Perényi J; Szûcs A; Debreczeni T
    Clin Neuropharmacol; 2000; 23(2):86-9. PubMed ID: 10803798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonic status epilepticus following high-dosage lamotrigine therapy.
    Guerrini R; Belmonte A; Parmeggiani L; Perucca E
    Brain Dev; 1999 Sep; 21(6):420-4. PubMed ID: 10487478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy.
    Cerminara C; Montanaro ML; Curatolo P; Seri S
    Neurology; 2004 Jul; 63(2):373-5. PubMed ID: 15277643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non convulsive status epilepticus after replacement of valproate with lamotrigine.
    Trinka E; Dilitz E; Unterberger I; Luef G; Deisenhammer F; Niedermüller U; Thaler C; Bauer G
    J Neurol; 2002 Oct; 249(10):1417-22. PubMed ID: 12382160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized myoclonus and spasticity induced by lamotrigine toxicity: a case report and literature review.
    Algahtani HA; Aldarmahi AA; Al-Rabia MW; Almalki WH; Bryan Young G
    Clin Neuropharmacol; 2014; 37(2):52-4. PubMed ID: 24614666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R; Brodie MJ
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonic astatic epilepsy (Doose syndrome) - a lamotrigine responsive epilepsy?
    Doege C; May TW; Siniatchkin M; von Spiczak S; Stephani U; Boor R
    Eur J Paediatr Neurol; 2013 Jan; 17(1):29-35. PubMed ID: 23159713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
    Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
    Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG.
    Bisulli F; Baruzzi A; Rosati A; Riva R; Avoni P; Cerullo A; Tinuper P
    Epileptic Disord; 2001 Sep; 3(3):151-6. PubMed ID: 11679308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy.
    Ferrie CD; Panayiotopoulos CP
    Seizure; 1994 Jun; 3(2):157-9. PubMed ID: 8081644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.